[{"_id":"551f897531cae9239deb1599","会社名":"(株)ＪＣＬバイオアッセイ【2190】","証券コード":"2190","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年5月8日","決算月数":"12か月","売上高":"2,207百万円","営業利益":"84百万円","経常利益":"172百万円","当期利益":"62百万円","EPS（一株当たり利益）":"18.08円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"270.83円","総資産":"3,808百万円","自己資本":"1,129百万円","資本金":"528百万円","有利子負債":"1,754百万円","自己資本比率":"29.6%","ROA（総資産利益率）":"1.64%","ROE（自己資本利益率）":"7.26%","総資産経常利益率":"4.54%","__v":0,"日付":"2015-04-04T06:49:25.561Z"},{"_id":"551f897531cae9239deb159a","会社名":"(株)ＪＣＬバイオアッセイ【2190】","証券コード":"2190","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月7日","決算月数":"12か月","売上高":"2,163百万円","営業利益":"-6百万円","経常利益":"111百万円","当期利益":"-136百万円","EPS（一株当たり利益）":"-41.16円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"175.22円","総資産":"3,765百万円","自己資本":"579百万円","資本金":"256百万円","有利子負債":"2,242百万円","自己資本比率":"15.4%","ROA（総資産利益率）":"-3.34%","ROE（自己資本利益率）":"-19.96%","総資産経常利益率":"2.73%","__v":0,"日付":"2015-04-04T06:49:25.561Z"},{"_id":"551f897531cae9239deb159b","会社名":"(株)ＪＣＬバイオアッセイ【2190】","証券コード":"2190","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月1日","決算月数":"12か月","売上高":"2,112百万円","営業利益":"-88百万円","経常利益":"-113百万円","当期利益":"-186百万円","EPS（一株当たり利益）":"-56.36円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"237.27円","総資産":"4,369百万円","自己資本":"784百万円","資本金":"256百万円","有利子負債":"2,538百万円","自己資本比率":"17.9%","ROA（総資産利益率）":"-4.52%","ROE（自己資本利益率）":"-20.81%","総資産経常利益率":"-2.74%","__v":0,"日付":"2015-04-04T06:49:25.561Z"},{"_id":"551f897531cae9239deb159c","会社名":"(株)ＪＣＬバイオアッセイ【2190】","証券コード":"2190","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年5月8日","決算月数":"12か月","売上高":"2,207百万円","営業利益":"84百万円","経常利益":"172百万円","当期利益":"62百万円","EPS（一株当たり利益）":"18.08円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"270.83円","総資産":"3,808百万円","自己資本":"1,129百万円","資本金":"528百万円","有利子負債":"1,754百万円","自己資本比率":"29.6%","ROA（総資産利益率）":"1.64%","ROE（自己資本利益率）":"7.26%","総資産経常利益率":"4.54%","__v":0,"日付":"2015-04-04T06:49:25.563Z"},{"_id":"551f897531cae9239deb159d","会社名":"(株)ＪＣＬバイオアッセイ【2190】","証券コード":"2190","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月7日","決算月数":"12か月","売上高":"2,163百万円","営業利益":"-6百万円","経常利益":"111百万円","当期利益":"-136百万円","EPS（一株当たり利益）":"-41.16円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"175.22円","総資産":"3,765百万円","自己資本":"579百万円","資本金":"256百万円","有利子負債":"2,242百万円","自己資本比率":"15.4%","ROA（総資産利益率）":"-3.34%","ROE（自己資本利益率）":"-19.96%","総資産経常利益率":"2.73%","__v":0,"日付":"2015-04-04T06:49:25.563Z"},{"_id":"551f897531cae9239deb159e","会社名":"(株)ＪＣＬバイオアッセイ【2190】","証券コード":"2190","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月1日","決算月数":"12か月","売上高":"2,112百万円","営業利益":"-88百万円","経常利益":"-113百万円","当期利益":"-186百万円","EPS（一株当たり利益）":"-56.36円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"237.27円","総資産":"4,369百万円","自己資本":"784百万円","資本金":"256百万円","有利子負債":"2,538百万円","自己資本比率":"17.9%","ROA（総資産利益率）":"-4.52%","ROE（自己資本利益率）":"-20.81%","総資産経常利益率":"-2.74%","__v":0,"日付":"2015-04-04T06:49:25.563Z"}]